Trials Sponsors Conditions Drugs Pricing

Conditions

Knee Osteoarthritis

Keywords

knee osteoarthritisplatelet rich plasmaozone therapy

Outcome Measures

Primary Outcomes (1)

Pain-Numerical Rating Scale
Pain level will be evaluated with the Numerical Rating Scale. (minimum: 0, maximum: 10)
From enrollment to the end of treatment at 3rd month

Secondary Outcomes (2)

Pain, stiffness and physical function-WOMAC
From enrollment to the end of treatment at 3rd month
Quality of life-SF-12
From enrollment to the end of treatment at 3rd month

Study Arms (2)

PRP group

Patients who received intra-articular PRP due to gonarthrosis

Other: PRP injection

Ozone group

Patients who received intra-articular ozone therapy due to gonarthrosis

Other: Ozone therapy

Interventions

PRP injectionOther

A total of 3 doses of intra-articular PRP were applied to the symptomatic knees of the patients under ultrasound guidance, once a week.

PRP group

Ozone therapyOther

A total of 3 doses of intra-articular ozone therapy were applied to the symptomatic knees of the patients under ultrasound guidance, once a week.

Ozone group

Eligibility Criteria

Age30 Years - 70 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Patients with Stage 2-3 gonarthrosis according to KL who apply to our hospital\'s Physical Medicine and Rehabilitation out-patient clinic will be included.

You may qualify if:

years old, Stage 2-3 gonarthrosis according to KL

Sponsors & Collaborators

Sisli Hamidiye Etfal Training and Research Hospital
Otherlead

Study Sites (1)

Şişli Hamidiye Etfal Training and Research Hospital, İstanbul

Istanbul, Turkey (Türkiye)

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

Banu Kuran, Professor
Şişli Hamidiye Etfal Training and Research Hospital
STUDY DIRECTOR

Enrollment

54 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: OTHER
Time Perspective: OTHER
Target Duration: 3 Months
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Medical Doctor

Study Record Dates

First Submitted

October 5, 2024

First Posted

October 8, 2024

Study Start

August 1, 2024

Actual (reported)

Effects of Platelet-Rich Plasma and Ozone Therapy in Knee Osteoarthritis

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (2)

PRP group

Ozone group

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (2)

PRP group

Ozone group

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations